Jessica Stitt, MBA

Treasurer Chief Financial Officer, Sonoma Biotherapeutics

Jessica Stitt, MBA is a global biotech financial executive with over 20 years of experience in corporate transactions, healthcare finance and strategy. She most recently served as Chief Financial Officer at Gyroscope Therapeutics, a global clinical-stage gene therapy company focused on disease of the eye, acquired by Novartis.

Prior to Gyroscope, Stitt served as Vice President of Finance and Operations for MyoKardia, Inc., a biopharmaceutical company developing targeted therapies for the treatment of serious cardiovascular diseases, acquired by Bristol Myers Squibb.

She served as Vice President of Finance and Investor Relations for Theravance Biopharma, Inc., after the company’s spin-off from Theravance, Inc., now Innoviva, Inc. She previously held roles in finance at Nektar Therapeutics, Alkermes and Blue Cross Blue Shield of Massachusetts.

Stitt holds an MBA from Simmons School of Management and a B.A. from Saint Anselm College.

You May Also Like.

Kiersten Betzer, MBA

Kiersten Betzer, MBA

Kiersten Betzer is a visionary leader in global marketing, sales, and general management, celebrated for her strategic...

read more
Samantha Bohrt 

Samantha Bohrt 

Samantha Bohrt holds a master’s degree in Public Health from the University of Texas Health Science Center at Houston....

read more
Celina Gorre

Celina Gorre

Celina Gorre has devoted her entire career to healthcare advocacy. Prior to WomenHeart, Celina served as Executive...

read more